nublexa tablet - Regorafenib (40mg) medicine

Nublexa Tablet (regorafenib 40mg): Comprehensive Guide

No reviews yet
🏭 Bayer Zydus Pharma Pvt Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 28, 2026
⚠️ Hepatotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High
Reviewed by
SaathiMed Expert Panel | Oct 28, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Yellowing of the skin or eyes, dark urine, or severe abdominal pain (possible liver injury).
  • Blood in stool or vomit, or coughing up blood (possible bleeding).
  • Severe chest pain, shortness of breath, or pain radiating to the arm or jaw (possible heart attack).
  • Sudden severe headache, confusion, seizures, or vision changes (possible RPLS).
  • Severe abdominal pain with fever and changes in bowel habits (possible gastrointestinal perforation).
  • Swelling of the face, lips, tongue, or throat, or difficulty breathing (possible allergic reaction).
  • Unusual fatigue, dizziness, or fainting (possible severe anemia or bleeding).

If experiencing severe symptoms, call emergency services immediately.

What is nublexa tablet used for?

This medicine is a prescription oral multikinase inhibitor used to treat metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. It works by blocking enzymes that promote tumor growth and blood vessel formation. The usual dose is 160 mg once daily for 21 days followed by 7 days off, taken with a low-fat meal. It can cause serious side effects, including liver injury, bleeding, and high blood pressure, so regular monitoring is essential.

  • Generic Name: Regorafenib (40mg)
  • Manufacturer: Bayer Zydus Pharma Pvt Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 nublexa tablet के बारे में (Hindi Summary)

उपयोग: यह दवा एक प्रिस्क्रिप्शन-आधारित कैंसर रोधी दवा है जिसमें रेगोराफेनिब सक्रिय घटक है। यह मेटास्टेटिक कोलोरेक्टल कैंसर, गैस्ट्रोइंटेस्टाइनल स्ट्रोमल ट्यूमर और हेपेटोसेलुलर कार्सिनोमा के इलाज के लिए उपयोग की जाती है। यह ट्यूमर की वृद्धि और रक्त वाहिकाओं के निर्माण को रोककर काम करती है। इसका उपयोग केवल कैंसर रोग विशेषज्ञ की देखरेख में ही किया जाना चाहिए।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में थकान, हाथ-पैर की त्वचा पर लालिमा या छाले, दस्त, भूख में कमी, उच्च रक्तचाप और मुँह के छाले शामिल हैं। गंभीर दुष्प्रभावों में यकृत की क्षति, रक्तस्राव, आंतों में छेद, दिल का दौरा और मस्तिष्क की एक दुर्लभ स्थिति शामिल हो सकती है। नियमित जांच और डॉक्टर से परामर्श आवश्यक है।

सुरक्षा सलाह: यह दवा केवल योग्य कैंसर रोग विशेषज्ञ की देखरेख में ही लें। रोज एक ही समय पर कम वसा वाले भोजन के साथ लें। गोली को पूरा निगलें, चबाएं नहीं। अंगूर और अंगूर के रस से बचें। अन्य दवाओं, सप्लीमेंट्स और जड़ी-बूटियों के बारे में डॉक्टर को बताएं। उपचार के दौरान और बाद में गर्भनिरोधक का उपयोग करें। स्तनपान न कराएं। रक्तचाप की नियमित निगरानी करें और असामान्य लक्षण तुरंत बताएं।

💡 Did You Know? The first generic medicine was introduced in India in 1970 after the Patents Act was amended.

💊 nublexa tablet Uses & Benefits

[{"condition":"Metastatic colorectal cancer","description":"Used in patients who have been previously treated with other therapies such as fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.","evidence":"Well-established"},{"condition":"Gastrointestinal stromal tumors (GIST)","description":"Indicated for patients with locally advanced, unresectable, or metastatic GIST who have failed prior treatment with imatinib and sunitinib.","evidence":"Well-established"},{"condition":"Hepatocellular carcinoma (HCC)","description":"Used as a second-line treatment for patients with hepatocellular carcinoma who have previously been treated with sorafenib.","evidence":"Well-established"}]

Off-label uses: [{"condition":"Refractory osteosarcoma","description":"Sometimes used off-label in patients with relapsed or refractory osteosarcoma based on small studies.","evidence":"Limited"},{"condition":"Advanced soft tissue sarcoma","description":"Occasionally used off-label in certain subtypes of soft tissue sarcoma after failure of standard therapies.","evidence":"Limited"}]

Primary treatment for: Metastatic colorectal cancer

Also treats: Gastrointestinal stromal tumors, Hepatocellular carcinoma

📋 Drug Information

Generic Name(s)Regorafenib (40mg)
Brand Namenublexa tablet
ManufacturerBayer Zydus Pharma Pvt Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassTyrosine kinase inhibitors
Route of AdministrationOral
StorageStore at room temperature between 20°C and 25°C (68°F to 77°F). Keep the tablets in their original blister pack or bottle, tightly closed, away from moisture and heat. Do not remove the desiccant. Keep out of reach of children.
Shelf Life24 months from the date of manufacture.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Take this medicine with a low-fat meal (less than 30% fat) to ensure consistent absorption and reduce stomach upset.
2
Monitor blood pressure weekly and report any readings above 140/90 mmHg to your doctor promptly.
3
Perform liver function tests before starting treatment and every 2 weeks for the first 2 months, then monthly.
4
Advise patients to use effective contraception during treatment and for at least 2 months after the last dose.
5
Instruct patients to report any signs of bleeding, such as blood in stool or urine, or unusual bruising, immediately.
6
Manage hand-foot skin reaction with moisturizers, padded footwear, and dose modification if severe.
7
Avoid concomitant use of strong CYP3A4 inhibitors or inducers; adjust dose if unavoidable.
8
Educate patients on the importance of not crushing or chewing the tablets and taking them at the same time each day.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Metastatic colorectal cancer
This medicine is approved for this condition after prior therapies.
Likely Use
✅
Gastrointestinal stromal tumor
This medicine is approved for GIST after failure of imatinib and sunitinib.
Likely Use
✅
Hepatocellular carcinoma
This medicine is approved for liver cancer after sorafenib.
Likely Use
❌
Fever
This medicine is not a fever reducer; it is used for cancer treatment.
Not Primary
❌
Common cold
This medicine is not used for infections or colds.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionFollowing oral administration, this medicine is absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached around 3 to 4 hours after a dose. The absolute bioavailability is approximately 69% to 83% when taken with a low-fat meal. A high-fat meal increases the exposure to this medicine and its active metabolites, which may increase toxicity. Therefore, it is recommended to take this medicine with a low-fat meal.
DistributionThis medicine is highly bound to plasma proteins and distributes extensively into tissues. The volume of distribution is not well characterized but is thought to be large. It crosses the blood-brain barrier to some extent. The active metabolite M-2 and M-5 also circulate in plasma.
Protein BindingRegorafenib and its active metabolites are highly bound to plasma proteins, primarily to albumin and lipoproteins. The protein binding is greater than 99%.
MetabolismThis medicine is primarily metabolized in the liver by cytochrome P450 enzymes, mainly CYP3A4 and UGT1A9. It undergoes oxidative metabolism to form active metabolites M-2 and M-5, which have similar potency to the parent drug. These metabolites are further metabolized and eliminated.
Half-LifeThe mean elimination half-life of regorafenib is approximately 28 hours (range 20-40 hours) for the parent drug, and 51 hours for the active metabolite M-2, and 62 hours for M-5.
ExcretionThis medicine is primarily excreted in the feces (approximately 71%) and to a lesser extent in the urine (approximately 19%). The majority of the dose is eliminated as metabolites.
BioavailabilityThe absolute bioavailability of this medicine is approximately 69% to 83% when administered with a low-fat meal. A high-fat meal increases the AUC by about 48% and Cmax by about 44%.
Onset of ActionThe onset of action is not immediate; it may take several weeks of treatment to observe clinical benefit. The pharmacodynamic effects begin after the first dose, but tumor response is typically assessed after 6-8 weeks.
Peak Plasma TimePeak plasma concentrations of this medicine are reached approximately 3 to 4 hours after oral administration with a low-fat meal.
Duration of ActionThe duration of action is related to the dosing schedule; with continuous daily dosing, the effects are sustained. The half-life of the active metabolites is long, so the effects may persist for several days after stopping the medicine.

How It Works

This medicine is a multikinase inhibitor that targets multiple protein kinases involved in tumor growth, angiogenesis, and the tumor microenvironment. It inhibits kinases such as VEGFR1, VEGFR2, VEGFR3, TIE2, PDGFR, FGFR, KIT, RET, RAF-1, BRAF, and BRAF V600E. By blocking these kinases, it interferes with signaling pathways that promote cancer cell proliferation, survival, and the formation of new blood vessels that supply the tumor. This dual action helps to slow tumor growth and progression.

Mechanism Steps

1
Binding to multiple kinases: This medicine binds to and inhibits a range of tyrosine kinases, including VEGFR, PDGFR, FGFR, KIT, RET, RAF, and BRAF, which are involved in cancer cell signaling.
2
Inhibition of angiogenesis: By blocking VEGFR and TIE2, this medicine reduces the formation of new blood vessels that supply the tumor, thereby starving cancer cells of oxygen and nutrients.
3
Inhibition of tumor cell proliferation: Inhibition of RAF, BRAF, KIT, and RET kinases disrupts signaling pathways that drive cancer cell division and survival.
4
Modulation of tumor microenvironment: This medicine also affects the tumor microenvironment by inhibiting PDGFR and FGFR, which can reduce fibrosis and improve drug delivery.
5
Induction of apoptosis: The combined inhibition of these pathways leads to increased programmed cell death of cancer cells and reduced tumor growth.

💡 How to Take nublexa tablet

Strength: 40 mg immediate-release tablet.

1Take this medicine at the same time each day, preferably in the morning.
2Take with a low-fat meal (less than 30% fat) to improve absorption and reduce stomach upset.
3Swallow the tablets whole with a glass of water. Do not crush, chew, or split the tablets.
4If you miss a dose, follow the missed dose instructions provided by your doctor.
5Do not take an extra dose to make up for a missed one.
6Avoid grapefruit and grapefruit juice while taking this medicine.
7Store the tablets in their original container, away from moisture and heat.

Dosage Information

Adult DosageThe recommended dose of this medicine is 160 mg (four 40 mg tablets) taken orally once daily for the first 21 days of each 28-day cycle, followed by 7 days off treatment. This dose must be individualized by a qualified clinician based on indication, patient's condition, and tolerability. Dose reductions may be necessary for adverse reactions. The maximum recommended dose is 160 mg per day. Always follow your oncologist's instructions.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly DosageNo specific dose adjustment is recommended for elderly patients based on age alone. However, elderly patients may be more sensitive to the effects of this medicine and should be monitored closely for adverse reactions. Dose selection should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and concomitant disease or other drug therapy.
Renal ImpairmentNo dose adjustment is recommended for patients with mild to moderate renal impairment. This medicine has not been studied in patients with severe renal impairment or end-stage renal disease. Use with caution in these patients and monitor closely for toxicity.
Hepatic ImpairmentNo dose adjustment is recommended for patients with mild to moderate hepatic impairment (Child-Pugh A or B). This medicine is contraindicated in patients with severe hepatic impairment (Child-Pugh C). Monitor liver function closely in all patients.
Maximum Daily Dose160 mg per day.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

Low-fat meal (less than 30% fat)
Take with a low-fat meal
Improves absorption and reduces variability. High-fat meals increase drug exposure and toxicity risk.
Grapefruit and grapefruit juice
Avoid
May increase levels of this medicine by inhibiting CYP3A4, leading to increased side effects.
St. John's wort
Avoid
May decrease levels of this medicine by inducing CYP3A4, reducing efficacy.

⏰ What to Do If You Miss a Dose

📌 Less than 12 hours have passed since the missed dose
→ Take the missed dose as soon as you remember on the same day.
💡 Continue with your regular schedule the next day.
📌 More than 12 hours have passed since the missed dose
→ Skip the missed dose and take your next dose at the regular time.
💡 Do not double dose to catch up.
📌 You vomit after taking a dose
→ Do not take another dose that day.
💡 Resume your normal schedule the next day.

⚠️ Side Effects of nublexa tablet

✅ Common Side Effects

Hand-foot skin reaction (Very common (>30%))
Moisturize hands and feet, avoid tight footwear, and use padded gloves/socks. Consult your doctor if severe; dose reduction may be needed.
Diarrhea (Common (30-40%))
Stay hydrated, avoid spicy foods, and use anti-diarrheal medications as advised by your doctor. Report if persistent.
Fatigue (Common (30-50%))
Get plenty of rest, pace your activities, and inform your doctor if it interferes with daily life.
High blood pressure (Common (30%))
Monitor blood pressure regularly. Your doctor may prescribe antihypertensive medication or adjust the dose.
Decreased appetite (Common (30-40%))
Eat small, frequent meals and high-calorie snacks. Consult a dietitian if weight loss occurs.
Mouth sores (Common (20-30%))
Maintain good oral hygiene, use a soft toothbrush, and rinse with salt water. Avoid acidic foods.

🚨 Serious Side Effects

Severe liver injury (Uncommon (1-5%))
Seek immediate medical attention if you experience yellowing of skin or eyes, dark urine, or severe abdominal pain. Regular liver function tests are required.
Hemorrhage (Uncommon (1-5%))
Report any signs of bleeding such as blood in stool, vomit, or urine, or unusual bruising. Seek emergency care if bleeding is severe.
Gastrointestinal perforation (Rare (<1%))
Seek immediate medical attention if you have severe abdominal pain, fever, or changes in bowel habits.
Cardiac ischemia or infarction (Uncommon (1-5%))
Call emergency services if you experience chest pain, shortness of breath, or pain radiating to the arm or jaw.
Reversible posterior leukoencephalopathy syndrome (RPLS) (Rare (<1%))
Seek immediate medical attention if you have severe headache, seizures, confusion, or vision changes.

⚠️ Rare Side Effects

Pancreatitis
Report severe abdominal pain radiating to the back, with nausea and vomiting.
Thyroid dysfunction
Regular thyroid function tests may be needed if symptoms of hypothyroidism or hyperthyroidism occur.
Allergic reactions
Seek immediate medical help if you experience rash, itching, swelling of face or throat, or difficulty breathing.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ketoconazole Major
Rifampin Major
Warfarin Major
Irinotecan Major
Diclofenac Moderate
Rosuvastatin Moderate
Amlodipine Moderate
Grapefruit juice Minor
St. John's wort Minor
Phenytoin Major

🚨 Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin)
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin)
  • Warfarin and other anticoagulants
  • Anticancer agents (e.g., irinotecan, oxaliplatin)

⚡ Moderate Interactions

  • UGT1A9 inhibitors (e.g., diclofenac, phenylbutazone)
  • BCRP substrates (e.g., rosuvastatin, methotrexate)
  • Antihypertensive agents

🍷 Alcohol Interaction

Alcohol may increase the risk of liver toxicity and gastrointestinal bleeding. It is advisable to avoid alcohol while taking this medicine. Consult your doctor for personalized advice.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Severe hepatic impairment (Child-Pugh C).","Known severe hypersensitivity to regorafenib or any component of the formulation.","Uncontrolled hypertension.","Recent or active severe bleeding.","Pregnancy and breastfeeding."]

⚠️ Warnings & Precautions

["This medicine can cause severe liver injury; monitor liver function closely.","May cause hypertension; monitor blood pressure and treat as needed.","Risk of bleeding; avoid concomitant anticoagulants if possible.","Can cause hand-foot skin reaction; manage with supportive care and dose modification.","May cause gastrointestinal perforation; seek immediate care for severe abdominal pain.","Can cause cardiac ischemia; monitor for chest pain.","May cause reversible posterior leukoencephalopathy syndrome (RPLS); report neurological symptoms.","Avoid use in patients with severe renal impairment; adjust dose if needed.","Use effective contraception during treatment and for 2 months after.","Do not breastfeed during treatment and for 2 weeks after."]

🤱 Lactation Safety

It is not known whether this medicine is present in human milk. Because of the potential for serious adverse reactions in breastfed infants, women should not breastfeed during treatment with this medicine and for at least 2 weeks after the last dose.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. In case of suspected overdose, discontinue the medicine and provide supportive care. Monitor vital signs and liver function. Gastric lavage may be considered if ingestion is recent. Contact a poison control center for guidance.

⏰ Missed Dose

If you miss a dose of this medicine, take it as soon as you remember on the same day. If it is almost time for your next dose (within 12 hours), skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. If you vomit after taking a dose, do not take another dose that day; resume your normal schedule the next day.

Additional Safety Advice

General Safety

This medicine must only be taken under the supervision of a qualified oncologist. Do not start, stop, or change the dose without consulting your doctor. Take the tablet at the same time each day, with a low-fat meal (containing less than 30% fat) to improve absorption and reduce stomach upset. Swallow the tablet whole with water; do not crush or chew it. Avoid grapefruit and grapefruit juice, as they can increase the levels of this medicine in your body. Inform your doctor about all other medicines, supplements, and herbal products you are taking, especially blood thinners, antibiotics, and antifungals. Use effective contraception during treatment and for at least 2 months after the last dose if you are of childbearing potential. Do not breastfeed while taking this medicine. Avoid activities that increase the risk of bleeding or injury. Monitor your blood pressure regularly and report any severe headache, vision changes, or chest pain immediately. Keep all appointments for blood tests and imaging. Store this medicine at room temperature away from moisture and heat.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients (above 65 years) may be more sensitive to the effects of this medicine, particularly fatigue, hypertension, and liver toxicity. No specific dose adjustment is recommended based on age alone, but close monitoring is advised. Dose selection should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and concomitant disease or other drug therapy.

🤰 Pregnancy Planning (TTC)

This medicine can cause fetal harm. Women of childbearing potential should use effective contraception during treatment and for at least 2 months after the last dose. Men with female partners of childbearing potential should also use effective contraception during treatment and for at least 2 months after the last dose. If you are planning to become pregnant, consult your doctor before starting or stopping this medicine.

🏥 Post-Surgery Considerations

This medicine can increase the risk of bleeding and impair wound healing. It should be stopped before any planned surgery, and your surgeon and oncologist should be informed. Typically, treatment should be interrupted at least 2 weeks before surgery and resumed only after adequate wound healing, as advised by your doctor. Monitor for signs of bleeding or infection after surgery.

🦷 Dental Procedures

This medicine can increase the risk of bleeding and infection. Inform your dentist that you are taking this medicine before any dental procedure. Your dentist may recommend postponing elective dental work until your blood counts and bleeding risk are assessed. For urgent dental procedures, your doctor may advise temporary interruption of this medicine. Maintain good oral hygiene to prevent dental problems.

💚 Lifestyle Tips for Better Results

🏃
Maintain a low-fat diet to improve absorption and reduce stomach upset.
🥗
Stay well hydrated, especially if you experience diarrhea or vomiting.
😴
Use moisturizers and padded footwear to prevent and manage hand-foot skin reaction.
💧
Monitor your blood pressure regularly at home and keep a log.
🧘
Get plenty of rest and pace your activities to manage fatigue.
🌞
Avoid alcohol to reduce the risk of liver toxicity and bleeding.
🚭
Practice good oral hygiene to prevent mouth sores.
🥑
Wash your hands frequently to reduce the risk of infection.

🏋️ Exercise Considerations

This medicine can cause fatigue, high blood pressure, and bleeding. Avoid strenuous exercise or activities that increase the risk of injury or bleeding. Light to moderate exercise, such as walking or swimming, may be beneficial, but consult your doctor before starting any exercise program. If you experience chest pain, shortness of breath, or dizziness during exercise, stop immediately and seek medical attention.

🥗 Diet Recommendations

Eat a low-fat diet with meals containing less than 30% fat.
Avoid grapefruit and grapefruit juice.
Avoid St. John's wort and other herbal supplements that may interact.
Include plenty of fluids to stay hydrated.
Eat small, frequent meals if you have decreased appetite.
Avoid spicy and acidic foods if you have mouth sores or diarrhea.
Ensure adequate protein intake to maintain strength.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, dizziness, and high blood pressure, which can affect your ability to drive or operate machinery. Avoid driving or operating heavy machinery until you know how this medicine affects you. You may need to adjust your work schedule to accommodate treatment cycles and medical appointments. Discuss any work-related concerns with your doctor and employer. Most patients can continue with light daily activities, but strenuous work may need to be modified.

🛑 When to Stop This Medicine

Do not stop taking this medicine without consulting your doctor. Treatment may be stopped if you experience severe or life-threatening side effects, if the cancer progresses, or if you decide with your doctor that the risks outweigh the benefits. Your doctor may also interrupt treatment temporarily for dose reduction or management of side effects. Always follow your oncologist's guidance regarding when to stop.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to cumulative toxicities, including liver injury, hypertension, hand-foot skin reaction, and fatigue. Regular monitoring of liver function, blood pressure, and blood counts is essential. Some patients may experience thyroid dysfunction or cardiac issues. The benefits of continued treatment should be weighed against the risks, and dose adjustments or treatment breaks may be necessary. Long-term survival benefits have been observed in clinical trials for approved indications.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Clinical trials

Enrollment in clinical trials of new therapies may be an option for patients who cannot tolerate or do not respond to this medicine.

Evidence: Varies
Palliative care

Palliative care can help manage symptoms and improve quality of life alongside cancer treatment.

Evidence: Well-established
Other targeted therapies

Depending on the cancer type and mutations, other targeted therapies or immunotherapies may be appropriate.

Evidence: Well-established for specific indications

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided during treatment with this medicine because of the potential for increased risk of infection. Inactivated vaccines may be administered, but their effectiveness may be reduced due to immunosuppression. Consult your doctor before receiving any vaccination.

📦 Storage Guide

✅ DO

Store at room temperature between 20°C and 25°C (68°F to 77°F).

❌ DON'T

Do not refrigerate or freeze.

✅ DO

Keep the tablets in their original blister pack or bottle, tightly closed.

❌ DON'T

Do not transfer to unmarked containers.

✅ DO

Keep away from moisture, heat, and direct sunlight.

❌ DON'T

Do not store in the bathroom cabinet.

✅ DO

Keep out of reach of children and pets.

❌ DON'T

Do not use after the expiry date.

✈️ Traveling with This Medicine

When traveling, carry this medicine in its original packaging with the prescription label. Bring a copy of your prescription and a letter from your doctor explaining that you are carrying this medicine for cancer treatment. Keep the medicine in your carry-on luggage to avoid loss or temperature extremes. Store at room temperature and avoid direct sunlight. If crossing time zones, maintain your dosing schedule as close to every 24 hours as possible; consult your doctor for specific advice. Check customs regulations for controlled substances in your destination country.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with metastatic colorectal cancer after failing standard chemotherapy.
He was started on this medicine at 160 mg daily for 21 days on and 7 days off. After the first cycle, he experienced hand-foot skin reaction and diarrhea, which were managed with dose reduction and supportive care. He learned to take the medicine with a low-fat breakfast and to moisturize his hands and feet regularly. After 3 months, his scans showed stable disease, and he was able to continue treatment with a better quality of life.
💡 Lesson: Early recognition and management of side effects, along with adherence to dietary advice, can help patients continue treatment and achieve better outcomes.
👤 A 65-year-old woman with advanced gastrointestinal stromal tumor after imatinib and sunitinib failure.
She was prescribed this medicine but initially took it with a high-fat meal, leading to severe fatigue and high blood pressure. Her doctor adjusted the timing to a low-fat meal and added antihypertensive medication. She also started monitoring her blood pressure at home. With these changes, her side effects became manageable, and she was able to stay on treatment for several months with stable disease.
💡 Lesson: Taking this medicine with a low-fat meal and monitoring blood pressure are crucial for tolerability and efficacy. Patient education is key.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine may take several weeks to show clinical benefit. Tumor response is typically assessed after 6-8 weeks of treatment. It is important to continue taking it as prescribed and attend all follow-up appointments.

Q: Can I take this medicine with food?

A: Yes, take this medicine with a low-fat meal (less than 30% fat). Avoid high-fat meals and grapefruit juice, as they can increase drug levels and side effects.

Q: What are the most common side effects?

A: The most common side effects include hand-foot skin reaction, diarrhea, fatigue, decreased appetite, high blood pressure, and mouth sores. Most can be managed with supportive care and dose adjustments.

Q: Can I stop taking this medicine if I feel better?

A: No, do not stop taking this medicine without consulting your doctor. Stopping suddenly may cause the cancer to progress. Your doctor will decide when and how to stop treatment.

Q: Is this medicine safe during pregnancy?

A: This medicine can cause fetal harm. Women of childbearing potential should use effective contraception during treatment and for at least 2 months after the last dose. Do not breastfeed during treatment and for 2 weeks after.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my liver function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • How do I manage hand-foot skin reaction?
  • Is it safe to take with other cancer drugs?
  • What should I do if I experience bleeding?
  • Can I take this medicine if I have kidney problems?

🔄 Substitutes for nublexa tablet

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can cure cancer.
    Fact: This medicine is not a cure for cancer. It can slow disease progression and extend survival but does not eliminate cancer completely.
  • Myth: You can stop taking this medicine once you feel better.
    Fact: You should not stop taking this medicine without consulting your doctor. Stopping suddenly may cause the cancer to progress.
  • Myth: This medicine has no serious side effects.
    Fact: This medicine can cause serious side effects, including liver injury, bleeding, and heart problems. Regular monitoring is required.
  • Myth: You can take this medicine with any food.
    Fact: This medicine should be taken with a low-fat meal. High-fat meals can increase drug levels and toxicity.

🔄 Alternative Options

Brand Alternatives

📊 Comparison with Similar Medicines

[{"medicine":"This medicine","class":"Multikinase inhibitor","primary_use":"Metastatic colorectal cancer, GIST, HCC","dosing":"160 mg once daily for 21 days on, 7 days off","common_side_effects":"Hand-foot skin reaction, diarrhea, fatigue, hypertension"},{"medicine":"Sorafenib","class":"Multikinase inhibitor","primary_use":"HCC, renal cell carcinoma","dosing":"400 mg twice daily continuously","common_side_effects":"Hand-foot skin reaction, diarrhea, fatigue, hypertension"},{"medicine":"Sunitinib","class":"Multikinase inhibitor","primary_use":"GIST, renal cell carcinoma","dosing":"50 mg once daily for 4 weeks on, 2 weeks off","common_side_effects":"Fatigue, diarrhea, nausea, hypertension"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory